Safety Labeling Changes for Erythropoiesis-Stimulating Agents (ESAs)
The FDA press release below is important to some men with prostate cancer. If you are currently taking Aranesp, Epogen or Procrit you should talk to your doctor about your risks and potential benefits. FDA Strengthens Boxed Warnings, Approves Other Safety Labeling Changes for Erythropoiesis-Stimulating Agents (ESAs) The U.S. Food and Drug Administration today approved [...]